β-Blocker Use Delays Motor Onset With Huntington Disease

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 17, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Dec. 17, 2024 -- β-blocker use is associated with delayed motor onset and worsening of motor symptoms with Huntington disease (HD), according to a study published online Dec. 2 in JAMA Neurology.

Jordan L. Schultz, Pharm.D., from Carver College of Medicine at the University of Iowa in Iowa City, and colleagues evaluated the impact of β-blockers on the timing of motor diagnosis onset and progression of HD symptoms. The analysis included 348 patients with genetically confirmed premanifest HD (preHD) and 298 with early motor-manifest HD (mmHD), with each group equally matched for β-blocker users and nonusers.

The researchers found that the preHD β-blocker users showed a statistically significant reduction in the annualized hazard of receiving a motor diagnosis versus nonusers (hazard ratio, 0.66). The mmHD β-blocker users had a slower mean annualized worsening in total motor score (mean difference, −0.45), total functional capacity score (mean difference, 0.10), and symbol digit modalities test (mean difference, 0.33) versus matched nonusers.

"These findings demonstrated that β-blockers may have a therapeutic role in HD," the authors write. "However, further studies are warranted to elucidate the possible mechanism by which β-blockers may positively influence HD outcomes."

One author serves as a consultant on a scientific advisory board for Novartis.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-18 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords